(Q7) Keystone Symposia: Parkinson’s Disease - Genetics, Mechanisms and Therapeutics
Conference - Keystone, CO, United States
The conference will:
• Delve into themes and mechanisms that appear to underlie Parkinson’s Disease, including protein aggregation, immune responses and mitochondrial dysfunction;
• Cover our current state of knowledge of the global genetic architecture of Parkinson’s, how this is informing cellular and molecular approaches to the etiology of the disease, and the implications of these discoveries in patient diagnosis and development of novel treatments;
• Explore the commonalities between Parkinson’s Disease and Alzheimer’s through joint sessions with the paired meeting on “Alzheimer’s Disease.”
Session Topics:
• Phenotypic and Genotypic Complexity of AD and PD (Joint)
• Genome-Wide Association and PD
• Biomarkers of AD and PD (Joint)
• Mitochondrial Biology and the Pathology of PD
• What Are the Toxic Species of Tau, Aβ and α-Synuclein (Joint)
• Pluripotent Stem Cells and Inherited PD
• Passive Immunization and Other Novel Therapies to Treat AD and PD? (Joint)
• LRRK2 Biology and PD Therapeutics
Organization: Keystone Symposia on Molecular and Cellular Biology
(Courtesy of Keystone Symposia: Parkinson’s Disease - Genetics, Mechanisms & Therapeutics logo, via parkinsonsnews.com)
(Q7) Keystone Symposia: Parkinson’s Disease - Genetics, Mechanisms and Therapeutics
Sun, Mar 02, 2014 - Fri, Mar 07, 2014
Keystone Resort, Keystone, Colorado, United States
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
